All In Biotech

Free tool

FAERS Monitor: Soolantra

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206255 or its brand name (Soolantra, Ivermectin). Reports on generic versions are filed under their own applications.

Reports

4,016

Serious

2,204

55% of reports

Hospitalization

1,080

Death reported

337

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective465
  • off label use420
  • product use in unapproved indication290
  • erythema224
  • headache201
  • pruritus184
  • rash163
  • rosacea161
  • fatigue154
  • nausea140
  • condition aggravated139
  • diarrhoea128
  • asthenia127
  • pyrexia125
  • skin burning sensation119

Reports by year received

View as table
YearReports
20056
20063
20073
20087
200912
20103
201111
20126
201331
201446
2015186
2016186
2017163
2018185
2019244
2020281
2021506
2022403
2023347
2024358
2025578
2026451

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,143 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rosaceaSignal161187.4160.628,648
skin burning sensationSignal1198.77.3806
product use in unapproved indicationSignal2906.15.51,254
erythemaSignal2245.75.0874
off label useSignal4202.52.3397
pruritusSignal1842.52.2168
condition aggravatedSignal1392.42.0113
rash1632.01.777
pyrexia1251.91.653
drug ineffective4651.81.7192
asthenia1271.81.542
headache2011.71.556
diarrhoea1281.00.90
fatigue1541.00.90
nausea1400.90.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.